News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,567 Results
Type
Article (39468)
Company Profile (247)
Press Release (654852)
Section
Business (204069)
Career Advice (2006)
Deals (35412)
Drug Delivery (93)
Drug Development (80976)
Employer Resources (170)
FDA (16145)
Job Trends (14836)
News (344963)
Policy (32485)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2544)
Accelerated approval (2)
Adcomms (20)
Allergies (78)
Alliances (49347)
ALS (79)
Alzheimer's disease (1330)
Antibody-drug conjugate (ADC) (99)
Approvals (16133)
Artificial intelligence (217)
Autoimmune disease (11)
Automation (14)
Bankruptcy (359)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (95)
Biotechnology (175)
Bladder cancer (50)
Brain cancer (24)
Breast cancer (238)
Cancer (1835)
Cardiovascular disease (139)
Career advice (1671)
Career pathing (28)
CAR-T (133)
Cell therapy (380)
Cervical cancer (14)
Clinical research (65490)
Collaboration (721)
Compensation (419)
Complete response letters (18)
COVID-19 (2576)
CRISPR (34)
C-suite (190)
Cystic fibrosis (97)
Data (1778)
Decentralized trials (2)
Denatured (15)
Depression (36)
Diabetes (228)
Diagnostics (6307)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (107)
Drug pricing (94)
Drug shortages (25)
Duchenne muscular dystrophy (70)
Earnings (85871)
Editorial (30)
Employer branding (21)
Employer resources (146)
Events (111332)
Executive appointments (607)
FDA (17147)
Featured Employer (48)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (646)
Gene editing (92)
Generative AI (18)
Gene therapy (264)
GLP-1 (665)
Government (4371)
Grass and pollen (4)
Guidances (47)
Healthcare (18792)
Huntington's disease (22)
IgA nephropathy (20)
Immunology and inflammation (93)
Indications (24)
Infectious disease (2697)
Inflammatory bowel disease (128)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (73)
Interviews (311)
IPO (16480)
IRA (40)
Job creations (3628)
Job search strategy (1421)
Kidney cancer (9)
Labor market (30)
Layoffs (442)
Leadership (14)
Legal (7895)
Liver cancer (70)
Lung cancer (267)
Lymphoma (125)
Machine learning (2)
Management (58)
Manufacturing (253)
MASH (57)
Medical device (13293)
Medtech (13298)
Mergers & acquisitions (19360)
Metabolic disorders (595)
Multiple sclerosis (62)
NASH (16)
Neurodegenerative disease (70)
Neuropsychiatric disorders (23)
Neuroscience (1774)
NextGen: Class of 2025 (6510)
Non-profit (4476)
Northern California (2274)
Now hiring (36)
Obesity (328)
Opinion (197)
Ovarian cancer (61)
Pain (71)
Pancreatic cancer (72)
Parkinson's disease (124)
Partnered (17)
Patents (186)
Patient recruitment (86)
Peanut (45)
People (56972)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20395)
Phase II (28842)
Phase III (21486)
Pipeline (852)
Podcasts (41)
Policy (103)
Postmarket research (2563)
Preclinical (8602)
Press Release (64)
Prostate cancer (86)
Psychedelics (30)
Radiopharmaceuticals (243)
Rare diseases (343)
Real estate (5899)
Recruiting (65)
Regulatory (22036)
Reports (43)
Research institute (2315)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (61)
Series A (115)
Series B (70)
Service/supplier (11)
Sickle cell disease (49)
Southern California (1963)
Special edition (14)
Sponsored (28)
Startups (3569)
State (2)
Stomach cancer (12)
Supply chain (58)
The Weekly (25)
United States (20012)
Vaccines (640)
Venture capitalists (35)
Webinars (12)
Weight loss (220)
Women's health (31)
Worklife (14)
Date
Last 7 days (575)
Last 30 days (2633)
Last 365 days (33789)
2025 (6466)
2024 (35217)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Alabama (48)
Alaska (7)
Arizona (215)
Arkansas (12)
Asia (37601)
Australia (6147)
California (5203)
Canada (1803)
China (426)
Colorado (237)
Connecticut (251)
Delaware (118)
Europe (80627)
Florida (773)
Georgia (181)
Idaho (57)
Illinois (470)
India (22)
Indiana (281)
Iowa (7)
Japan (131)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (796)
Massachusetts (3934)
Michigan (206)
Minnesota (354)
Mississippi (2)
Missouri (73)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (62)
New Jersey (1478)
New Mexico (28)
New York (1489)
North Carolina (882)
North Dakota (7)
Northern California (2274)
Ohio (181)
Oklahoma (13)
Oregon (33)
Pennsylvania (1182)
Puerto Rico (7)
Rhode Island (24)
South America (1093)
South Carolina (16)
South Dakota (1)
Southern California (1963)
Tennessee (87)
Texas (765)
Utah (160)
Virginia (121)
Washington D.C. (56)
Washington State (494)
West Virginia (3)
Wisconsin (47)
694,567 Results for "discgenics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
DiscGenics to Present at Canaccord Genuity 2024 Musculoskeletal Conference
DiscGenics, Inc. today announced that Flagg Flanagan, Chief Executive Officer and Chairman of DiscGenics will present at Canaccord Genuity’s 2024 Musculoskeletal Conference.
February 8, 2024
·
2 min read
BioMidwest
DiscGenics to Present at Biotech Showcase 2024
DiscGenics, Inc. announced that Flagg Flanagan, Chief Executive Officer and Chairman of DiscGenics is presenting at Biotech Showcase 2024.
January 4, 2024
·
2 min read
BioMidwest
DiscGenics CEO to Present at Upcoming Industry Conferences
DiscGenics, Inc. announced that Flagg Flanagan, Chief Executive Officer and Chairman of DiscGenics will present at the following conferences.
September 26, 2023
·
2 min read
DiscGenics to Present at Canaccord Genuity’s 2023 Musculoskeletal Conference
DiscGenics, Inc. today announced that it will present at Canaccord Genuity’s 18th Annual Musculoskeletal Conference taking place in Las Vegas, NV on Tuesday, March 7, 2023.
February 28, 2023
·
1 min read
BioMidwest
DiscGenics to Present at 41st Annual J.P. Morgan Healthcare Conference
DiscGenics, Inc. announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference taking place in San Francisco, CA on January 9 – 12, 2023.
January 4, 2023
·
1 min read
DiscGenics to Present at 2022 Cell & Gene Meeting on the Mesa
DiscGenics, Inc. today announced that Flagg Flanagan, Chief Executive Officer and Chairman will present virtually at the annual Cell & Gene Meeting on the Mesa to be held October 11-13 in Carlsbad, California and livestreamed globally.
October 5, 2022
·
2 min read
DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease
DiscGenics, Inc. today announced the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to Injectable Disc Cell Therapy (IDCT or rebonuputemcel), an injectable, allogeneic discogenic progenitor cell therapy for the treatment of symptomatic lumbar degenerative disc disease (DDD).
January 26, 2023
·
3 min read
DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease
DiscGenics, Inc. today announced positive two-year clinical data from its first-in-human clinical study of IDCT (rebonuputemcel), an allogeneic discogenic progenitor cell therapy for lumbar degenerative disc disease (DDD).
January 23, 2023
·
8 min read
Two-Year Clinical Data for DiscGenics’s Progenitor Cell Therapy for Lumbar Disc Degeneration to Be Presented at NASS 2022
DiscGenics, Inc. today announced that Matthew F. Gornet, MD, Board Certified Spine Surgeon at The Orthopedic Center of St. Louis, will present two-year follow-up data from the Company’s first-in-human clinical study of its allogeneic discogenic progenitor cell therapy (IDCT) for lumbar disc degeneration at the North American Spine Society (NASS) 37th Annual Meeting.
October 11, 2022
·
3 min read
Press Releases
FOXO TECHNOLOGIES INC. PROVIDES UPDATE ON ITS BEHAVIORAL HEALTH SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC.
March 12, 2025
·
3 min read
1 of 69,457
Next